Back to news
REGULATORYMarijuana Moment

Appeal challenges Medicare Advantage hemp and CBD coverage pilot

Marijuana prohibition groups and a pharmaceutical company filed an appellate brief seeking to block a CMS pilot that can cover up to $500 a year in qualifying hemp-derived products for eligible Medicare Advantage patients. The case could shape national reimbursement and market access for cannabinoid products, so Oklahoma operators should track the standing dispute and the government's response due November 4.

Share this update

FacebookXLinkedInEmail

#national#hemp#litigation#market-access

Read the original source

Leafy summaries provide industry context. Confirm details with Marijuana Moment.

Open source

Continue reading

Related industry updates